Copyright
©The Author(s) 2018.
World J Gastroenterol. Oct 28, 2018; 24(40): 4554-4564
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4554
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4554
Sex (F/M) | Age (yr) | BMI (kg/m2) | Fibroscan index | Treatment-naïve /experienced | ALT/AST(U/L)-baseline | ALT/AST(U/L)-week 2 | Log HCV RNA | Response to sofosbuvir/ledipasvir |
F | 27 | 18.71 | 3.8 | N | 25/25 | 10/19 | 6.16 | SVR24 |
M | 62 | 15.85 | 6.5 | N | 55/47 | 24/23 | 6.09 | SVR24 |
F | 30 | 20.07 | 5.9 | N | 18/20 | 10/19 | 6.38 | SVR24 |
F | 53 | 20.10 | 3.9 | N | 11/25 | 6/19 | 6.98 | SVR24 |
M | 25 | 24.39 | 6.1 | N | 43/22 | 23/18 | 4.60 | SVR24 |
F | 27 | 19.38 | 7.9 | N | 20/20 | 11/22 | 6.87 | SVR24 |
F | 29 | 26.67 | 6.4 | N | 32/24 | 16/14 | 5.90 | SVR24 |
M | 24 | 29.33 | 7.6 | E | 85/75 | 10/16 | 6.45 | SVR24 |
M | 63 | 25.10 | 4.8 | E | 50/32 | 31/23 | 6.51 | SVR24 |
M | 55 | 23.62 | 4.5 | E | 34/30 | 24/20 | 6.56 | SVR24 |
F | 57 | 22.31 | 4.7 | E | 20/26 | 15/20 | 6.76 | SVR24 |
F | 63 | 26.75 | 4.3 | E | 27/29 | 11/19 | 6.76 | SVR24 |
M | 25 | 26.53 | 6.0 | E | 30/23 | 11/22 | 6.60 | SVR24 |
- Citation: Wang XX, Luo BF, Jiang HJ, Cong X, Jin Q, Ma DL, Wei L, Feng B. Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir. World J Gastroenterol 2018; 24(40): 4554-4564
- URL: https://www.wjgnet.com/1007-9327/full/v24/i40/4554.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i40.4554